Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

44results about How to "High anticancer activity" patented technology

Polygonatum cyrtonema leaf enzyme extraction polysaccharide as well as preparation method and application thereof

The preparation method comprises the following steps: degreasing polygonatum cyrtonema leaf superfine powder, sequentially carrying out ultrasonic-assisted enzymolysis treatment on cellulase, xylanase, high-temperature-resistant alpha-amylase, papain and saccharifying enzyme, and carrying out alcohol precipitation, dialysis and vacuum freeze drying treatment to obtain the polygonatum cyrtonema leaf polysaccharide. The polygonatum cyrtonema leaf enzyme extraction crude polysaccharide is obtained; and separating the enzyme-extracted crude polysaccharide through a cellulose column, and purifying through a sephadex column to obtain the polygonatum cyrtonema leaf enzyme-extracted polysaccharide. Polysaccharide in polygonatum cyrtonema leaves is extracted through ultrasonic-assisted compound enzyme, single pure polysaccharide is obtained through alcohol precipitation, dialysis, cellulose column chromatography and gel column chromatography, and the purity can reach 99.86%; the obtained enzyme extraction polysaccharide has good anti-cancer activity, can significantly inhibit proliferation of breast cancer cells and colorectal cancer cells, has the characteristics of good biocompatibility, strong specificity, low toxic and side effects and the like, and has wide application prospects.
Owner:嘉兴未来食品研究院

A curcumin 2-chloroadenine derivative compound

The present invention relates to a curcumin 2-chloroadenine derivative compound or a stereoisomer, a deuterated substance, a solvate, a prodrug, a metabolite, a pharmaceutically acceptable salt or a cocrystal thereof.
Owner:BOHAI UNIV

Preparation method and application of closed-loop feedback-regulation nano drug delivery system

The invention belongs to the technical field of drug carriers, and particularly discloses a preparation method and application of a closed-loop feedback-regulation nano drug delivery system.The preparation method comprises the following steps that a starting material containing a reversible molecular library is provided, and the reversible molecular library is prepared in a buffer salt system; under thermodynamic control, adding anti-cancer drug molecules and guest molecules into the starting material; through a reversible covalent reaction process, molecules in an initial material spontaneously form a self-assembled nano-carrier containing drug molecules under the combined action of the drug molecules and guest molecules. According to the preparation method and application of the closed-loop feedback-regulation nano drug delivery system, reversible covalent reaction, closed-loop feedback-regulation and self-assembly technologies are combined, spontaneous construction of a nano carrier is achieved, and the nano carrier is endowed with excellent drug loading capacity, stability and environmental responsiveness.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Tumor-targeted nano drug delivery system as well as preparation method and application thereof

The invention provides a tumor targeted nano drug delivery system and a preparation method and application thereof, the tumor targeted nano drug delivery system comprises a PD-L1 monoclonal antibody, radix pseudostellariae cyclic peptide B and an mPEG-PLGA-NH2 nano carrier, the radix pseudostellariae cyclic peptide B is encapsulated in the mPEG-PLGA-NH2 nano carrier, and the outer surface of the mPEG-PLGA-NH2 nano carrier is modified with the PD-L1 monoclonal antibody. The tumor-targeted nano drug delivery system has good anti-cancer activity and biocompatibility, has longer circulation time and higher bioavailability, is obviously superior to free drugs in the aspects of tumor resistance and immunoregulation, and is expected to be applied to preparation of tumor-targeted drugs, especially gastric cancer-targeted drugs.
Owner:HUZHOU CENT HOSPITAL

Bispecific antibodies and uses thereof

The invention discloses a bispecific antibody targeting CD3 and PD-L1 and an application of the bispecific antibody. The bispecific antibody comprises a first antigen binding region, a second antigen binding region and an Fc part, the Fc part comprises a first Fc peptide fragment and a second Fc peptide fragment; the first antigen binding region comprises an scFv fragment and a binding protein of a first molecule or a fragment thereof, the binding protein of the first molecule or the fragment thereof is connected with the N end of the scFv fragment, and the C end of the scFv fragment is connected with the N end of the first Fc peptide fragment; the second antigen binding region comprises a binding protein of a second molecule or a fragment thereof, and the binding protein of the second molecule or the fragment thereof is connected with the N end of the second Fc peptide fragment; the first molecule and the second molecule are PD-L1, and the scFv fragment has CD3 binding activity. The bispecific antibody disclosed by the invention is good in safety, high in anti-cancer activity and high in clinical application and drug development value.
Owner:HEFEI TG IMMUNOPHARMA CO LTD

Application of ginkgetin in enhancing VS4718 or ponatinib in resisting esophageal squamous cell carcinoma progress

The invention provides an application of ginkgetin in enhancing VS4718 or ponatinib in resisting the progress of esophageal squamous cell carcinoma. It is found that ginkgo biflavone can enhance the growth and invasion inhibition effect of VS4718 or ponatinib on esophageal squamous carcinoma cells; ginkgo biflavone is used for enhancing the inhibition effect of VS4718 or ponatinib on glycolipid metabolism of tumor cells, and the ginkgo biflavone is respectively combined with VS4718 or ponatinib to generate a synergistic anti-cancer effect.
Owner:BEIJING CANCER HOSPITAL PEKING UNIV CANCER HOSPITAL

Preparation method and application of tris (2-methyl-2-phenylpropyl) tin-3, 5-dichlorosalicylate complex

The invention discloses a preparation method and application of a tris (2-methyl-2-phenylpropyl) stann-3, 5-dichlorosalicylate complex, and the tris (2-methyl-2-phenylpropyl) stann-3, 5-dichlorosalicylate complex is a complex # imgabs0 # with the following structural formula (I). The invention also discloses a preparation method of the tris (2-methyl-2-phenylpropyl) stann-3, 5-dichlorosalicylate complex and an application of the tris (2-methyl-2-phenylpropyl) stann-3, 5-dichlorosalicylate complex in preparation of antitumor drugs.
Owner:HENGYANG NORMAL UNIV

N-heterocyclic dithiocarbamate Fe (III) compound as well as preparation method and application thereof

The invention discloses an N-heterocyclic dithiocarbamate Fe (III) compound as well as a preparation method and application thereof. The chemical formula of the target Fe (III) compound is [FeIII (L)]. ClO4.H2O, wherein HL is a (E)-methyl 2-(quinoline-8-methylene) hydrazino dithioformate Schiff base ligand. The Fe (III) compound is simple in preparation route, high in yield and easy to purify. The Fe (III) compound shows hemolytic activity equivalent to that of cis-platinum, and shows good biocompatibility. An MTT (Methyl Thiazolyl Tetrazolium) experiment shows that the Fe (III) compound has good anti-cancer activity, and the Fe (III) compound realizes relatively high photothermal conversion efficiency in an aqueous solution under illumination of near-infrared laser of 650 nm. Therefore, the Fe (III) compound not only can be used for chemotherapy of tumors, but also can be used for photothermal therapy.
Owner:苟峄

12-nitrogen substituted matrine ester derivative, preparation method and application thereof

ActiveCN116354962BGood suppression functionHigh anticancer activityOrganic active ingredientsOrganic chemistryCancer cellPharmaceutical Substances
The invention discloses a 12-nitrogen substituted matrine ester derivative, a preparation method and an application thereof, and relates to the technical field of development and application of natural product derivatives of medicinal chemistry. Aiming at the disadvantages of the natural product matrine, such as low bioavailability, poor activity and large dosage, which limit its wide application, the invention hydrolyzes matrine and prepares matrine ester, and then replaces and transforms the 12-nitrogen substituted matrine ester derivatives to prepare a series of 12-nitrogen substituted matrine ester derivatives. Anti-tumor activity experiments show that the derivatives have good anti-cancer activity, and in particular have good inhibitory function on liver cancer and lung cancer cells.
Owner:GUANGXI UNIV

Preparation method and application of ATAP polypeptide and vaccine thereof

The present invention discloses a preparation method and application of an ATAP polypeptide and a vaccine thereof. The ATAP polypeptide is a protein of the following a) or b): a) any one of the amino acid sequences shown in SEQ ID NO: 1, 2, 3, 4, wherein an intramolecular disulfide bond is formed between the two Cys residues at amino acid positions 30 and 38 in SEQ ID NO: 1, 2, 3, 4, and b) a protein derived from a) in which the amino acid sequence in a) is substituted, deleted or added with one or more amino acids and has a cancer prevention effect. The present invention also discloses the application of the ATAP polypeptide or a pharmaceutically acceptable salt thereof in the preparation of a drug for preventing and treating cancer.
Owner:BEIJING AITAIPU BIOMEDICAL TECH CO LTD

Tripterine-luteolin self-assembled nanoparticles as well as preparation method and application thereof

PendingCN121818551AReduce drug concentrationEfficient encapsulationPowder deliveryOrganic active ingredientsNanoparticlePharmaceutical drug
The invention relates to tripterine-luteolin-based self-assembled nanoparticles as well as a preparation method and application thereof, and belongs to the field of biological medicines. Compared with single tripterine, the tripterygium wilfordii derivative nano-particles provided by the invention have a stronger inhibition effect on tumor cells and lower toxicity, and have a good application prospect in the development of antitumor drugs.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY

A metal complex tailed with a TDO inhibitor and its preparation method and application

The present invention discloses a metal complex tailed with a TDO inhibitor, and its preparation method and application. The preparation method of the metal complex tailed with a TDO inhibitor of the present invention is specifically as follows: in a light-proof and inert gas environment, a metal dimer precursor and a dechlorinating agent are added to anhydrous methanol, refluxed and stirred at 60°C for 0.2 to 72 hours, and filtered after the reaction; an immune checkpoint TDO inhibitor ligand is added to the filtrate, and the reaction is carried out in an anaerobic environment. After the reaction is complete, an anion salt is added thereto, the solution is filtered and concentrated, and then frozen. After freezing, centrifugation is performed to obtain a crude product, which is purified by column chromatography to obtain a metal complex. The aryl / cyclopentadienyl metal complex of the present invention can be well positioned in the nucleus of cancer cells, induce cell necrosis, lead to immunogenic cell death, and inhibit the expression of immune checkpoint TDO, thereby achieving good anticancer activity, ICD induction activity and immune checkpoint TDO inhibition activity.
Owner:NANJING NORMAL UNIVERSITY

Novel CRS fragment peptide with immunological enhancement activity and application thereof

The invention relates to a novel CRS fragment peptide with immunological enhancement activity and application of the novel CRS fragment peptide. More specifically, the present invention relates to a novel peptide consisting of the amino acid sequence of SEQ ID NO: 2 or an amino acid sequence having 95% or higher sequence homology thereto and a vaccine adjuvant, their use as a cancer therapeutic agent and an antiviral composition. The peptides disclosed herein are CRS fragment peptides disclosed herein for the first time, exhibiting anticancer activity, immunological enhancement and antiviral activity.
Owner:ZYMEDI CO LTD

Preparation method and application of bis [tri (2-methyl-2-phenylpropyl) tin] 5-sulfosalicylate complex

The invention discloses a preparation method and application of a bis [tri (2-methyl-2-phenylpropyl) tin] 5-sulfosalicylate complex. The bis [tri (2-methyl-2-phenylpropyl) tin] 5-sulfosalicylate complex is a complex # imgabs0 # with the following structural formula (I). The invention further discloses a preparation method of the bis [tri (2-methyl-2-phenylpropyl) tin] 5-sulfosalicylate complex and application of the bis [tri (2-methyl-2-phenylpropyl) tin] 5-sulfosalicylate complex in preparation of antitumor drugs.
Owner:HENGYANG NORMAL UNIV

Chiral C7-functionalized 4-aminoindole compound, and preparation method and application thereof

The invention discloses a chiral C7-functionalized 4-aminoindole compound, and belongs to the technical field of organic chemical synthesis, the compound has a structure as shown in a formula (I); meanwhile, the invention also discloses a preparation method of the compound, which comprises the following steps: dissolving benzothiophene ketimine and 4-aminoindole in an organic solvent, then adding a chiral phosphoric acid catalyst, stirring and reacting at 0-30 DEG C, and after the reaction is finished, separating and purifying to obtain the compound. The compound provided by the invention has a tetra-substituted carbon atom center and also has indole and benzothiophene substructures with pharmacodynamic functional groups, more candidate molecules can be provided for research and development of new drugs and screening of drugs, and the compound shows a better application prospect in the anti-tumor aspect; the preparation method disclosed by the invention has the advantages of novelty, simplicity, simplicity in operation, mild reaction conditions, low catalyst dosage, high yield, high stereoselectivity and the like.
Owner:CHENGDU UNIV

Preparation method and application of bis (tricyclohexyltin) 5-sulfosalicylate complex

The invention discloses a preparation method and application of a bis (tricyclohexyltin) 5-sulfosalicylate complex. The bis (tricyclohexyltin) 5-sulfosalicylate complex is a complex # imgabs0 # with a structural formula (I) as shown in the specification. The invention also discloses a preparation method of the bis (tricyclohexyltin) 5-sulfosalicylate complex and application of the bis (tricyclohexyltin) 5-sulfosalicylate complex in preparation of antitumor drugs.
Owner:HENGYANG NORMAL UNIV

Preparation method and application of tricyclohexyltin 2-hydroxy-3-naphthoic acid ester complex

The invention discloses a preparation method and application of a tricyclohexyltin 2-hydroxy-3-naphthoic acid ester complex. The tricyclohexyltin 2-hydroxy-3-naphthoic acid ester complex is a complex # imgabs0 # with the following structural formula (I). The invention further discloses a preparation method of the tricyclohexyltin 2-hydroxy-3-naphthoic acid ester complex and application of the tricyclohexyltin 2-hydroxy-3-naphthoic acid ester complex in preparation of antitumor drugs.
Owner:HENGYANG NORMAL UNIV

Cytohormone fusion proteins

PendingCN119562973AHigh anticancer activitySmall systemic side effectsAntibody mimetics/scaffoldsPeptide/protein ingredientsTumor microenvironmentEffector cell
The present invention relates to a cytohormone fusion protein comprising a cytohormone domain that can specifically induce an immune cell targeting domain and proliferation and / or activation of immune cells. Specifically, the present invention relates to a fusion protein that specifically delivers a cytohormone (e.g., IL-2 or IL-15) to a depleted immune cell (e.g., a depleted T cell) within a tumor, thereby inducing and enhancing the activation of the immune cell. The fusion protein according to the present invention can selectively deliver a cytohormone that promotes the proliferation or activation of immune cells to effector T cells or the like in a tumor microenvironment, thereby inducing a strong immune enhancement and anti-cancer response in a tumor. Moreover, through the unique structure of the cytohormone action domain, systemic toxicity and even side effects caused by the cytohormone can be obviously reduced.
Owner:GENUV INC

Preparation method and application of C3 position cyanoalkyl substituted quinoxalinone

The invention belongs to the field of electrochemistry and green synthesis, and particularly relates to a preparation method and application of quinoxalinone substituted by cyanoalkyl at the C3 position. The preparation method comprises the following steps: by taking quinoxalinone and acrylonitrile as reaction raw materials, adding an electrolyte, an organic solvent and an additive, and carrying out electrolytic reaction to obtain the C3-position cyanoalkyl substituted quinoxalinone. The method for electrolytically synthesizing the C3-position cyanoalkyl substituted quinoxalinone is reported for the first time, acrylonitrile which is low in price and easy to obtain serves as an alkyl source, pre-activation of a substrate is not needed, operation is easy, cost is low, the atom utilization rate is high, participation of a chemical redox reagent is not needed, the reaction temperature is room temperature, and the method is suitable for industrial production. The C3-position cyanoalkyl substituted quinoxalinone can be efficiently and greenly synthesized; the quinoxalinone substituted by cyanoalkyl at the C3 position has good anti-cancer activity, can be used for preparing anti-cancer drugs, and has important application value.
Owner:ANYANG INST OF TECH

Polysaccharide-assisted tea extract as well as preparation method and application thereof

The invention relates to a polysaccharide-assisted tea extract as well as a preparation method and application thereof. Fresh tea leaves are soaked with an aloe polysaccharide solution, tea leaves obtained through filtration are dried in the sun to obtain dry tea leaves, then the dry tea leaves are soaked with filtrate obtained through filtration again and then filtered, the tea leaves are subjected to pure water soaking and high-temperature and high-pressure treatment to obtain tea leaf liquid, and the tea leaf liquid is subjected to concentration, pure water hydrolysis and high-temperature and high-pressure treatment to obtain hydrolyzed tea leaf liquid. And mixing the filtrate obtained by filtering the hydrolyzed tea liquid with the filtrate obtained in the previous step, filtering, concentrating and drying. The ethanol aqueous solution can dissolve soluble substances of the aloe polysaccharide, and insoluble impurities are removed in the subsequent filtering step. According to the method, effective substances of the tea leaves are extracted under the assistance of the polysaccharide, the EGCG content in the tea leaves can be greatly increased, and the anticancer activity of the tea extract is improved through the synergistic effect of the aloe polysaccharide and active substances in the tea extract.
Owner:广州市东源药业科技有限公司 +1

A polypeptide with anticancer activity and its preparation method and application

PendingCN122587004AEasy to adjustHigh anticancer activity
The application belongs to the technical fields of medicinal chemistry and antitumor drugs, and discloses a polypeptide with anticancer activity, a preparation method and application thereof. The polypeptide is a Bathiapeptide F analogue containing a thiazole or dithiazole skeleton, and the molecular structure of the polypeptide contains independently changeable amino acid residue or peptide residue substituents. The application designs and synthesizes a new polypeptide analogue containing a thiazole or dithiazole skeleton by taking Bathiapeptide F as a parent structure. The preparation method includes the steps of amination reaction, sulfuration reaction, thiazole ring formation reaction, amide condensation reaction, ester hydrolysis, and removal of an amino protecting group. Experimental results show that the polypeptide has obvious inhibitory effect on Huh7 liver cancer cells, MDA-MB-231 breast cancer cells and A375 melanoma cells, and can be used for preparing anticancer drugs, and has good drug development prospects.
Owner:SHENZHEN TECH UNIV +1

Novel compound, pharmaceutical composition containing the same and use thereof

The present invention relates to a novel compound, a pharmaceutical composition for preventing or treating resistant cancer comprising the novel compound or a pharmaceutically acceptable salt thereof, and use thereof. When the composition of the present invention is administered together with an anticancer agent, it can exhibit an excellent anticancer effect.
Owner:HEALING MEDICINE CO LTD

A semi-sandwich structure iridium ferrocene pyridine complex and its preparation method and application

The invention discloses a semi-sandwich structure iridium ferrocene pyridine complex, a preparation method thereof and an anti-cancer application thereof. Its structural formula is shown in formula (I), R is methyl, phenyl or biphenyl, and the double bond is in cis and trans configurations. By testing the growth inhibition rate of the target complex on human alveolar basal epithelial cancer cells, cervical cancer cells and normal human lung epithelial cells, and comparing them, it is found that the target complex exhibits good anti-cancer activity, confirming the synergistic anti-cancer effect of ferrocene and metal iridium complexes. The substituent R is changed from methyl→phenyl→biphenyl, and the activity of the complex is effectively improved, confirming that improving the electron donation ability of the ligand is conducive to improving the anti-cancer activity of such complexes. In addition, the trans-configuration complex also shows higher activity. The target complex can accumulate in the lysosome in A549 cells and cause lysosome damage, thereby causing cancer cell death. The complex shows a certain selectivity between normal cells and cancer cells.
Owner:SHEN ZHEN WAN ZHI DA XIN XI ZI XUN YOU XIAN GONG SI

Preparation method of diterpenoid and application thereof

ActiveCN117582426Bpromote apoptosisHigh anticancer activity
The application discloses a preparation method of diterpenoid compounds and application thereof. Ten diterpenoid compounds are separated from Euphorbia fischeriana, including six kinds of atisine type diterpenoid compounds, two kinds of gansuine type diterpenoid compounds, one kind of taxodine type diterpenoid compound and one kind of sequirine type diterpenoid compound. The diterpenoid compounds have the effect of promoting apoptosis of SW1990 pancreatic cancer cells, wherein the anticancer activity of compounds 1, 3 and 9 is better than that of positive drug paclitaxel, and the compounds can be used as leading compounds of anti-pancreatic cancer drugs, and also provide a basis and a new idea for extraction and medicinal research of the diterpenoid compounds.
Owner:YUNNAN UNIVERSITY OF CHINESE MEDICINE

Preparation method and application of silver / copper alloy nanoparticles

The invention belongs to the field of biomedical nano materials, and discloses a preparation method and application of silver / copper alloy nano particles. The preparation method comprises the steps that a Cu < 2 + > and Ag < + > mixed solution containing polyvinylpyrrolidone is prepared, an ascorbic acid solution is added, parameters are adjusted, the Cu-coated AgNPs nanoparticles are prepared, the particle size of the prepared nanoparticles ranges from 80 nm to 100 nm, and the Cu-coated AgNPs nanoparticles are applied to preparation of inhibition drugs for food-borne pathogenic bacteria and conventional breast cancer cells. The process for preparing the silver / copper alloy nanoparticles (Cu (at) AgNPs) is simple, convenient and rapid, and is easy to operate. The silver / copper alloy nanoparticles provided by the invention integrate the activities of silver and copper metal nanoparticles, so that the defect that copper is easy to oxidize is overcome, the defects of toxicity and high price of silver are weakened, the biocompatibility is increased, and the silver / copper alloy nanoparticles have better economic value, have higher stability and better dispersity, are not easy to oxidize, and have good application prospects. And copper ions and silver ions are not easy to release in advance under physiological conditions. The material has a good photothermal effect, can be used as a photosensitive material to realize co-delivery of chemotherapy and thermal therapy, is a combination of a novel copper death mode and a common cell death mode, and has a remarkable antibacterial and anticancer effect.
Owner:DALIAN POLYTECHNIC UNIVERSITY

A strain of Bacillus CCPM7645 with strong anticancer activity and its application

The present invention relates to a strain of Bacillus CCPM7645 with strong anticancer activity and its application, belonging to the field of biopharmaceutical technology. In order to solve the problem of large side effects of existing anticancer drugs, the present invention provides a strain of Bacillus CCPM7645 with strong anticancer activity, belonging to the genus Bacillus (Bacillus), representing a new bacterial species, which has been preserved in the General Microbiological Center of the China Microbiological Culture Collection Administration Committee, and the preservation number is CGMCC No.17887. The bacteria originates from the human intestine and is a new source of Bacillus, which can produce anticancer active metabolites, and its metabolites can be used to treat cancer. Since it is found in the human intestine, it has very low or no side effects on the human body, which solves the problems of large side effects of current anticancer drugs and poor patient compliance, and is expected to achieve the purpose of preventing cancer by regulating the balance of intestinal flora.
Owner:INNER MONGOLIA DAHUANG GUOMENG BIOTECHNOLOGY CO LTD

Artificial ion transport system and application of light-driven molecular motor with antibacterial and antitumor activities

The present invention discloses an artificial ion transport system and application of a light-driven molecular motor with antibacterial and anti-tumor activity. The general structural formula of a light-driven molecular motor with a large steric olefin and unidirectional rotation is shown in any one of Formulas I to III: #imgabs0# The light-driven molecular motor with a multi-substituted large steric olefin provided by the present invention is a type of transporter molecule that can be inserted into a phospholipid bilayer membrane for light-controlled ion transmembrane transport, and has the advantages of controllable structure and easy derivatization. Transmembrane transport molecules can selectively transport ions across the membrane, and accelerate ion transmembrane transport by driving the motor movement through light, thereby realizing light-controlled and time-space precise gated ion transmembrane transport. In addition, the molecule can realize light-regulated ion transport on cell membranes and bacterial membranes, destroy the balance of ions inside and outside the cell to achieve excellent photosensitivity antibacterial and anti-tumor activity, and has good application prospects in the field of biomedicine.
Owner:EAST CHINA UNIV OF SCI & TECH

A tetravalent platinum complex derived from cinnamic acid, its preparation method and application

This invention belongs to the field of pharmaceutical technology, specifically relating to a tetravalent platinum complex based on cinnamic acid, its preparation method, and its application. This invention is the first to introduce a cinnamic acid group into the structure of a tetravalent platinum complex, designing and synthesizing a series of novel platinum-based anticancer prodrugs, namely cinnamic acid-platinum (IV) complexes. Biological evaluation shows that these complexes exhibit stronger anticancer activity than classic divalent platinum drugs and good selectivity for cancer cells, demonstrating the potential of highly effective, low-toxicity, and drug-resistant novel anticancer drugs.
Owner:HEBEI UNIVERSITY

T cell production method

Disclosed is a method for producing T cells, the method comprising: a step (1) of culturing a three-dimensional cell aggregate comprising cells that can be differentiated into T cells and stromal cells that express Notch ligands derived from pluripotent stem cells. A T cell obtained by the method and a drug comprising the T cell are also disclosed.
Owner:KYOTO UNIV +1

Preparation method and application of tricyclohexyltin 1-hydroxy-2-naphthoic acid ester complex

The invention discloses a preparation method and application of a tricyclohexyltin 1-hydroxy-2-naphthoic acid ester complex. The tricyclohexyltin 1-hydroxy-2-naphthoic acid ester complex is a complex # imgabs0 # with the following structural formula (I). The invention further discloses a preparation method of the tricyclohexyltin 1-hydroxy-2-naphthoic acid ester complex and application of the tricyclohexyltin 1-hydroxy-2-naphthoic acid ester complex in preparation of antitumor drugs.
Owner:HENGYANG NORMAL UNIV